https://www.marketscreener.com/quote/stock/EVAXION-BIOTECH-A-S-118683095/news/Evaxion-announces-promising-results-from-Phase-1-2a-clinical-trial-of-personalized-DNA-cancer-immuno-42343355/?utm_source=telegram&utm_medium=social&utm_campaign=share